Giant Coronary Artery Aneurysm after Drug-Eluting Stent (DES
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
Introduction of Drug-Eluting Stent (DES) proved to be an important step forward in reducing rates of restenosis and target lesion revascularization after percutaneous coronary intervention, but at the same time potentially causing serious complications. One of the rare complications of DES is coronary artery aneurysm. Coronary Artery Aneurysm (CAA), defined as localized dilatation of the coronary artery exceeding 50% of the reference vessel diameter is considered as very rare, with a reported incidence of 0.3-6% after percutaneous coronary intervention. It is termed as giant if diameter exceeds the reference vessel diameter by four times or if the aneurysm is 8 mm or more.We report a case of giant coronary artery aneurysm presented with acute myocardial infarction, which was successfully treated by sequential implantation of two covered stents. At 2-month follow-up, the patient presented with mass effect of the thrombosis aneurysm compressing the right ventricle, improved with conservative management....

http://vascular-endovascular-surgery.imedpub.com/giant-coronary-artery-aneurysm-after-drugeluting-stent-des-implantation-therapeutic-challenges-and-management.php?aid=18595
Like
Comment
Share